Language of document :

Notice for the OJ

 

     JUDGMENT OF THE COURT OF FIRST INSTANCE

     26 November 2002

In Joined Cases T-74/00, T-76/00, T-83/00 to T-85/00, T-132/00, T-137/00 and T-141/00: Artegodan GmbH and Others v Commission of the European Communities(1)

    (Medicinal products for human use ( Community arbitration procedures ( Withdrawal of marketing authorisations ( Competence ( Criteria for withdrawal ( Anorectics: amfepramone, clobenzorex, fenproporex,

norpseudoephedrine, phentermine ( Directives 65/65/EEC and 75/319/EEC)

    (Language of the case: German, English and French)

In Joined Cases T-74/00, T-76/00, T-83/00 to T-85/00, T-132/00, T-137/00 and T- 141/00, Artegodan GmbH, established in Lüchow (Germany), represented by U. Doepner, lawyer, with an address for service in Luxembourg, applicant in Case T-74/00, Bruno Farmaceutici SpA, established in Rome (Italy), Essential Nutrition Ltd, established in Brough (United Kingdom), Hoechst Marion Roussel Ltd, established in Denham (United Kingdom), Hoechst Marion Roussel SA, established in Brussels (Belgium), Marion Merell SA, established in Puteaux (France), Marion Merell SA, established in Barcelona (Spain), Sanova Pharma GmbH, established in Vienna (Austria), Temmler Pharma GmbH & Co. KG, established in Marburg (Germany), represented by B. Sträter and M. Ambrosius, lawyers, with an address for service in Luxembourg, applicants in Case T-76/00, Schuck GmbH, established in Schwaig (Germany), represented by B. Sträter and M. Ambrosius, lawyers, with an address for service in Luxembourg, applicant in Case T-83/00, Laboratórios Roussel Lda, established in Mem Martins (Portugal), represented by B. Sträter and M. Ambrosius, lawyers, with an address for service in Luxembourg, applicant in Cases T-84/00 and T-85/00, Laboratoires Roussel Diamant SARL, established in Puteaux (France), represented by B. Sträter and M. Ambrosius, lawyers, with an address for service in Luxembourg, applicant in Case T-84/00, Roussel Iberica SA, established in Barcelona (Spain), represented by B. Sträter and M. Ambrosius, lawyers, with an address for service in Luxembourg, applicant in Case T-85/00, Gerot Pharmazeutika GmbH, established in Vienna (Austria), represented by K. Grigkar, lawyer, with an address for service in Luxembourg, applicant in Case T-132/00, Cambridge Healthcare Supplies Ltd, established in Norfolk (United Kingdom), represented by D. Vaughan, K. Bacon, barristers, and S. Davis, solicitor, with an address for service in Luxembourg, applicant in Case T-137/00, Laboratoires pharmaceutiques Trenker SA, established in Brussels, represented by L. Defalque and X. Leurquin, lawyers, with an address for service in Luxembourg, applicant in Case T-141/00, v Commission of the European Communities (Agents: H. Støvlbæk, R. Wainwright and B. Wägenbaur): Application for annulment of the Commission decisions of 9 March 2000 concerning the withdrawal of marketing authorisations of medicinal products for human use containing respectively 'amfepramone' (C(2000) 453), as regards Cases T-74/00, T-76/00 and T-141/00, inter alia 'norpseudoephedrine', 'clobenzorex' and 'fenproporex' (C(2000) 608), as regards Cases T-83/00 to T-85/00, and 'phentermine' (C(2000) 452), as regards Cases T-132/00 and T-137/00, the Court of First Instance (Second Chamber, Extended Composition), composed of: R.M. Moura Ramos, President, V. Tiili, J. Pirrung, P. Mengozzi and A.W.H. Meij, Judges; D. Christensen, Administrator, for the Registrar, has given a judgment on 26 November 2002, in which it:

1.Annuls the Commission Decisions of 9 March 2000 (C(2000) 452, C(2000) 453 and C(2000) 608) in so far as they relate to the medicinal products marketed by the applicants;

2.Orders the Commission to pay all the costs, including those incurred in the interlocutory proceedings.

____________

1 - OJ C 149 of 27.5.2000, C 163 of 10.6.2000, C 192 of 8.7.2000 and C 233 of 12.8.2000.